MicroBase Technology

MicroBase Technology Revenue per Share

The Revenue per Share of MicroBase Technology (3184.TWO) as of Nov 20, 2026 is 2.64 TWD. In the previous year, Revenue per Share was 2.68 TWD — a change of -1.43% (lower).

Revenue per Share

2.64TWD

YoY

-1.43%

Last updated:

Revenue per Share of MicroBase Technology is 2025 2.64 TWD. Revenue per Share of MicroBase Technology was 2024 2.68 TWD. It decreases by -1.43% lower compared to the previous year.

The MicroBase Technology Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2017
2.78 TWD
Jan 1, 2018
6.40 TWD
Jan 1, 2020
3.22 TWD
Jan 1, 2021
2.65 TWD
Jan 1, 2022
2.27 TWD
Jan 1, 2023
2.43 TWD
Jan 1, 2024
2.68 TWD
Jan 1, 2025
2.64 TWD
The MicroBase Technology Revenue per Share history
YEARRevenue per ShareYoY
2.64TWD-1.43%
2.68TWD+10.27%
2.43TWD+6.84%
2.27TWD-14.36%
2.65TWD-17.55%
3.22TWD-49.79%
6.40TWD+130.46%
2.78TWD+21.24%
2.29TWD-10.70%
2.57TWD+6.74%
2.40TWD-63.99%
6.68TWD-33.46%
10.03TWD+64.85%
6.09TWD-16.25%
7.27TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MicroBase Technology Stock analysis

What does MicroBase Technology do? MicroBase Technology Corp, listed on the Taiwan Stock Exchange under ticker 3184.TWO, is a health care company headquartered in Taoyuan, Taiwan. The company has 48 employees and completed its initial public offering on April 18, 2013. MicroBase Technology Corp engages in the production, planning, and maintenance of medical equipment. The company's product portfolio includes the Inkjet Printer Nozzle Plate, Microneedle Patch, Aerosol Generator Head, Nebulizer, and Soft Mist Inhaler, among others. These products are distributed both domestically within Taiwan and internationally to overseas markets. The company operates within the health care sector, focusing on medical equipment solutions. MicroBase Technology Corp maintains a website at https://microbasetech.com/ for further information. The company's operations are centered around the development and distribution of specialized medical devices, with an emphasis on both local and global market reach. As a publicly traded entity, it provides transparency through its financial disclosures and corporate governance practices. The firm's activities are primarily conducted in Taoyuan, Taiwan, reflecting its regional operational base. MicroBase Technology Corp's business model involves the manufacturing and maintenance of medical equipment, targeting both domestic and international customers through its product offerings. MicroBase Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MicroBase Technology stock

Revenue per Share of MicroBase Technology is 2.64 TWD in 2025.

Revenue per Share of MicroBase Technology changed from 2.68 TWD to 2.64 TWD, representing a -1.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share MicroBase Technology since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MicroBase Technology

All Key Metrics — MicroBase Technology